A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection

Clinical trial NCT02640157 · COMPLETED

Trial details

NCT number: NCT02640157
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C Hepatitis C Virus Genotype 3 Hepatitis C Virus

Start date: 2015-12-01
Primary completion: 2016-10-01
Enrollment: 506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.